跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,257 条关于
“Davis Polk LLP”
全部
5,257
临床试验
1,971
药物
698
机构
1,681
资讯
907
去年
Precigen Secures $125 Million Credit Facility to Advance PAPZIMEOS Commercialization
去年
Sycamore Partners Completes $11.45 Per Share Acquisition of Walgreens Boots Alliance
11个月前
ADC Therapeutics Secures $60 Million to Advance ZYNLONTA Commercialization and Prepare for 2027 Relaunch
2个月前
Talawar Therapeutics to Go Public via SPAC Merger, Secures $225M PIPE to Advance Bispecific Antibody for Atopic Dermatitis
去年
ADC Therapeutics Secures $100 Million Financing to Advance ZYNLONTA Development Through 2028
去年
Humacyte Faces Class Action Lawsuit Over Manufacturing Practices and FDA Review Delay
2个月前
ChemDiv CNS Platform Drives Neurodegenerative Programs into Clinic for Brenig and Polku Therapeutics
去年
Applied Therapeutics Faces Investor Lawsuit Over Govorestat Data Disclosure
去年
FDA's Draft Guidance on Clinical Trial Diversity: Challenges and Implications
去年
UC Davis Health Premieres Documentary on Duchenne Muscular Dystrophy Gene Therapy Trial
第 1 页,共 91 页
上一页
下一页